nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—ALPL—osteoporosis	0.843	1	CbGaD
Fospropofol—ALB—Estropipate—osteoporosis	0.0322	0.707	CbGbCtD
Fospropofol—ALB—Estradiol—osteoporosis	0.0134	0.293	CbGbCtD
Fospropofol—Tingling sensation—Calcium Acetate—osteoporosis	0.00462	0.0534	CcSEcCtD
Fospropofol—Stinging—Calcium Acetate—osteoporosis	0.00458	0.053	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—PTH1R—osteoporosis	0.00259	0.102	CbGpPWpGaD
Fospropofol—Tingling sensation—Conjugated Estrogens—osteoporosis	0.00173	0.02	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—PTH—osteoporosis	0.00136	0.0536	CbGpPWpGaD
Fospropofol—Hypotension—Calcium Acetate—osteoporosis	0.00124	0.0143	CcSEcCtD
Fospropofol—Paraesthesia—Calcium Acetate—osteoporosis	0.00119	0.0138	CcSEcCtD
Fospropofol—Pain—Calcium Acetate—osteoporosis	0.00113	0.0131	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—PTHLH—osteoporosis	0.00113	0.0444	CbGpPWpGaD
Fospropofol—Pain—Ergocalciferol—osteoporosis	0.001	0.0116	CcSEcCtD
Fospropofol—Angiopathy—Estropipate—osteoporosis	0.000961	0.0111	CcSEcCtD
Fospropofol—Mediastinal disorder—Estropipate—osteoporosis	0.000954	0.011	CcSEcCtD
Fospropofol—Pruritus—Calcium Acetate—osteoporosis	0.000937	0.0108	CcSEcCtD
Fospropofol—Angiopathy—Raloxifene—osteoporosis	0.000931	0.0108	CcSEcCtD
Fospropofol—Angiopathy—Ibandronate—osteoporosis	0.000921	0.0107	CcSEcCtD
Fospropofol—Mediastinal disorder—Ibandronate—osteoporosis	0.000915	0.0106	CcSEcCtD
Fospropofol—Vomiting—Calcium Acetate—osteoporosis	0.000842	0.00974	CcSEcCtD
Fospropofol—Cough—Estropipate—osteoporosis	0.000805	0.0093	CcSEcCtD
Fospropofol—Nausea—Calcium Acetate—osteoporosis	0.000787	0.0091	CcSEcCtD
Fospropofol—Paraesthesia—Etidronic acid—osteoporosis	0.000781	0.00903	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00078	0.00901	CcSEcCtD
Fospropofol—Cough—Raloxifene—osteoporosis	0.000779	0.00901	CcSEcCtD
Fospropofol—Angiopathy—Ethinyl Estradiol—osteoporosis	0.000779	0.00901	CcSEcCtD
Fospropofol—Angiopathy—Risedronate—osteoporosis	0.000759	0.00878	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000755	0.00873	CcSEcCtD
Fospropofol—Mediastinal disorder—Risedronate—osteoporosis	0.000754	0.00872	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000747	0.00864	CcSEcCtD
Fospropofol—Nervous system disorder—Estropipate—osteoporosis	0.000738	0.00853	CcSEcCtD
Fospropofol—Skin disorder—Estropipate—osteoporosis	0.000731	0.00845	CcSEcCtD
Fospropofol—Angiopathy—Pamidronate—osteoporosis	0.000722	0.00835	CcSEcCtD
Fospropofol—Mediastinal disorder—Pamidronate—osteoporosis	0.000717	0.00829	CcSEcCtD
Fospropofol—Nervous system disorder—Raloxifene—osteoporosis	0.000715	0.00827	CcSEcCtD
Fospropofol—Skin disorder—Raloxifene—osteoporosis	0.000708	0.00819	CcSEcCtD
Fospropofol—Nervous system disorder—Ibandronate—osteoporosis	0.000708	0.00818	CcSEcCtD
Fospropofol—Skin disorder—Ibandronate—osteoporosis	0.000701	0.0081	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—RAP1A—osteoporosis	0.000699	0.0276	CbGpPWpGaD
Fospropofol—Nausea—Ergocalciferol—osteoporosis	0.000695	0.00804	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—AGER—osteoporosis	0.000691	0.0272	CbGpPWpGaD
Fospropofol—Skin disorder—Calcitriol—osteoporosis	0.000686	0.00793	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—SPP1—osteoporosis	0.000683	0.0269	CbGpPWpGaD
Fospropofol—Paraesthesia—Estropipate—osteoporosis	0.000676	0.00781	CcSEcCtD
Fospropofol—Angiopathy—Zoledronate—osteoporosis	0.000659	0.00763	CcSEcCtD
Fospropofol—Mediastinal disorder—Zoledronate—osteoporosis	0.000655	0.00757	CcSEcCtD
Fospropofol—Cough—Ethinyl Estradiol—osteoporosis	0.000652	0.00754	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Estropipate—osteoporosis	0.00065	0.00751	CcSEcCtD
Fospropofol—Paraesthesia—Ibandronate—osteoporosis	0.000648	0.00749	CcSEcCtD
Fospropofol—Pain—Estropipate—osteoporosis	0.000643	0.00744	CcSEcCtD
Fospropofol—Cough—Risedronate—osteoporosis	0.000636	0.00735	CcSEcCtD
Fospropofol—Angiopathy—Conjugated Estrogens—osteoporosis	0.000635	0.00734	CcSEcCtD
Fospropofol—Pain—Alendronate—osteoporosis	0.000634	0.00733	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000632	0.00731	CcSEcCtD
Fospropofol—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000631	0.00729	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000629	0.00728	CcSEcCtD
Fospropofol—Pain—Raloxifene—osteoporosis	0.000623	0.00721	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000623	0.0072	CcSEcCtD
Fospropofol—Pain—Ibandronate—osteoporosis	0.000617	0.00714	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000616	0.00712	CcSEcCtD
Fospropofol—Pruritus—Etidronic acid—osteoporosis	0.000615	0.00712	CcSEcCtD
Fospropofol—Cough—Pamidronate—osteoporosis	0.000604	0.00699	CcSEcCtD
Fospropofol—Pain—Calcitriol—osteoporosis	0.000604	0.00699	CcSEcCtD
Fospropofol—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000598	0.00692	CcSEcCtD
Fospropofol—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000592	0.00685	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—BMP2—osteoporosis	0.000589	0.0232	CbGpPWpGaD
Fospropofol—Nervous system disorder—Risedronate—osteoporosis	0.000583	0.00674	CcSEcCtD
Fospropofol—Skin disorder—Risedronate—osteoporosis	0.000578	0.00668	CcSEcCtD
Fospropofol—Nervous system disorder—Pamidronate—osteoporosis	0.000554	0.00641	CcSEcCtD
Fospropofol—Vomiting—Etidronic acid—osteoporosis	0.000553	0.0064	CcSEcCtD
Fospropofol—Cough—Zoledronate—osteoporosis	0.000552	0.00638	CcSEcCtD
Fospropofol—Headache—Etidronic acid—osteoporosis	0.000545	0.0063	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000535	0.00619	CcSEcCtD
Fospropofol—Paraesthesia—Risedronate—osteoporosis	0.000534	0.00617	CcSEcCtD
Fospropofol—Pruritus—Estropipate—osteoporosis	0.000532	0.00616	CcSEcCtD
Fospropofol—Cough—Conjugated Estrogens—osteoporosis	0.000532	0.00615	CcSEcCtD
Fospropofol—Hypotension—Pamidronate—osteoporosis	0.000528	0.00611	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000527	0.00609	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—IRS1—osteoporosis	0.000526	0.0207	CbGpPWpGaD
Fospropofol—Pruritus—Alendronate—osteoporosis	0.000524	0.00606	CcSEcCtD
Fospropofol—Nausea—Etidronic acid—osteoporosis	0.000517	0.00597	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000515	0.00596	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Risedronate—osteoporosis	0.000513	0.00594	CcSEcCtD
Fospropofol—Pruritus—Ibandronate—osteoporosis	0.00051	0.0059	CcSEcCtD
Fospropofol—Pain—Risedronate—osteoporosis	0.000509	0.00588	CcSEcCtD
Fospropofol—Angiopathy—Estradiol—osteoporosis	0.000508	0.00588	CcSEcCtD
Fospropofol—Paraesthesia—Pamidronate—osteoporosis	0.000508	0.00587	CcSEcCtD
Fospropofol—Nervous system disorder—Zoledronate—osteoporosis	0.000506	0.00586	CcSEcCtD
Fospropofol—Mediastinal disorder—Estradiol—osteoporosis	0.000505	0.00584	CcSEcCtD
Fospropofol—Skin disorder—Zoledronate—osteoporosis	0.000502	0.0058	CcSEcCtD
Fospropofol—Pruritus—Calcitriol—osteoporosis	0.0005	0.00578	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—IGF1—osteoporosis	0.0005	0.0197	CbGpPWpGaD
Fospropofol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000488	0.00564	CcSEcCtD
Fospropofol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000488	0.00564	CcSEcCtD
Fospropofol—Pain—Pamidronate—osteoporosis	0.000483	0.00559	CcSEcCtD
Fospropofol—Skin disorder—Conjugated Estrogens—osteoporosis	0.000483	0.00558	CcSEcCtD
Fospropofol—Hypotension—Zoledronate—osteoporosis	0.000482	0.00558	CcSEcCtD
Fospropofol—Vomiting—Estropipate—osteoporosis	0.000478	0.00553	CcSEcCtD
Fospropofol—Headache—Estropipate—osteoporosis	0.000471	0.00545	CcSEcCtD
Fospropofol—Vomiting—Alendronate—osteoporosis	0.000471	0.00545	CcSEcCtD
Fospropofol—Hypotension—Conjugated Estrogens—osteoporosis	0.000465	0.00537	CcSEcCtD
Fospropofol—Headache—Alendronate—osteoporosis	0.000464	0.00537	CcSEcCtD
Fospropofol—Paraesthesia—Zoledronate—osteoporosis	0.000464	0.00536	CcSEcCtD
Fospropofol—Vomiting—Raloxifene—osteoporosis	0.000463	0.00536	CcSEcCtD
Fospropofol—Vomiting—Ibandronate—osteoporosis	0.000459	0.00531	CcSEcCtD
Fospropofol—Headache—Raloxifene—osteoporosis	0.000457	0.00528	CcSEcCtD
Fospropofol—Headache—Ibandronate—osteoporosis	0.000452	0.00523	CcSEcCtD
Fospropofol—Vomiting—Calcitriol—osteoporosis	0.000449	0.00519	CcSEcCtD
Fospropofol—Nausea—Estropipate—osteoporosis	0.000447	0.00517	CcSEcCtD
Fospropofol—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000446	0.00516	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000446	0.00516	CcSEcCtD
Fospropofol—Headache—Calcitriol—osteoporosis	0.000442	0.00512	CcSEcCtD
Fospropofol—Pain—Zoledronate—osteoporosis	0.000442	0.00511	CcSEcCtD
Fospropofol—Nausea—Alendronate—osteoporosis	0.00044	0.00509	CcSEcCtD
Fospropofol—Nausea—Raloxifene—osteoporosis	0.000433	0.00501	CcSEcCtD
Fospropofol—Pruritus—Ethinyl Estradiol—osteoporosis	0.000431	0.00499	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000429	0.00496	CcSEcCtD
Fospropofol—Nausea—Ibandronate—osteoporosis	0.000429	0.00496	CcSEcCtD
Fospropofol—Cough—Estradiol—osteoporosis	0.000425	0.00492	CcSEcCtD
Fospropofol—Pain—Conjugated Estrogens—osteoporosis	0.000425	0.00492	CcSEcCtD
Fospropofol—Pruritus—Risedronate—osteoporosis	0.000421	0.00487	CcSEcCtD
Fospropofol—Nausea—Calcitriol—osteoporosis	0.00042	0.00485	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000412	0.00477	CcSEcCtD
Fospropofol—Pruritus—Pamidronate—osteoporosis	0.0004	0.00462	CcSEcCtD
Fospropofol—Nervous system disorder—Estradiol—osteoporosis	0.00039	0.00451	CcSEcCtD
Fospropofol—Vomiting—Ethinyl Estradiol—osteoporosis	0.000388	0.00448	CcSEcCtD
Fospropofol—Skin disorder—Estradiol—osteoporosis	0.000387	0.00447	CcSEcCtD
Fospropofol—Headache—Ethinyl Estradiol—osteoporosis	0.000382	0.00442	CcSEcCtD
Fospropofol—Vomiting—Risedronate—osteoporosis	0.000378	0.00437	CcSEcCtD
Fospropofol—Headache—Risedronate—osteoporosis	0.000373	0.00431	CcSEcCtD
Fospropofol—Pruritus—Zoledronate—osteoporosis	0.000365	0.00422	CcSEcCtD
Fospropofol—Nausea—Ethinyl Estradiol—osteoporosis	0.000362	0.00419	CcSEcCtD
Fospropofol—Vomiting—Pamidronate—osteoporosis	0.000359	0.00416	CcSEcCtD
Fospropofol—Paraesthesia—Estradiol—osteoporosis	0.000357	0.00413	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—SPP1—osteoporosis	0.000357	0.0141	CbGpPWpGaD
Fospropofol—Headache—Pamidronate—osteoporosis	0.000354	0.0041	CcSEcCtD
Fospropofol—Nausea—Risedronate—osteoporosis	0.000353	0.00408	CcSEcCtD
Fospropofol—Pruritus—Conjugated Estrogens—osteoporosis	0.000352	0.00407	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Estradiol—osteoporosis	0.000344	0.00397	CcSEcCtD
Fospropofol—Pain—Estradiol—osteoporosis	0.00034	0.00394	CcSEcCtD
Fospropofol—Nausea—Pamidronate—osteoporosis	0.000336	0.00388	CcSEcCtD
Fospropofol—GABRG3—Orphan transporters—ANXA2—osteoporosis	0.000331	0.013	CbGpPWpGaD
Fospropofol—Vomiting—Zoledronate—osteoporosis	0.000328	0.0038	CcSEcCtD
Fospropofol—GABRB1—Orphan transporters—ANXA2—osteoporosis	0.000326	0.0128	CbGpPWpGaD
Fospropofol—Headache—Zoledronate—osteoporosis	0.000323	0.00374	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—IRS2—osteoporosis	0.000323	0.0127	CbGpPWpGaD
Fospropofol—Vomiting—Conjugated Estrogens—osteoporosis	0.000316	0.00366	CcSEcCtD
Fospropofol—Headache—Conjugated Estrogens—osteoporosis	0.000311	0.0036	CcSEcCtD
Fospropofol—GABRA6—Orphan transporters—ANXA2—osteoporosis	0.000308	0.0122	CbGpPWpGaD
Fospropofol—Nausea—Zoledronate—osteoporosis	0.000307	0.00355	CcSEcCtD
Fospropofol—GABRA4—Orphan transporters—ANXA2—osteoporosis	0.000304	0.012	CbGpPWpGaD
Fospropofol—ALPL—Endochondral Ossification—TGFB1—osteoporosis	0.0003	0.0118	CbGpPWpGaD
Fospropofol—Nausea—Conjugated Estrogens—osteoporosis	0.000295	0.00342	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—IRS1—osteoporosis	0.000282	0.0111	CbGpPWpGaD
Fospropofol—Pruritus—Estradiol—osteoporosis	0.000282	0.00326	CcSEcCtD
Fospropofol—GABRB2—Orphan transporters—ANXA2—osteoporosis	0.000278	0.011	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—WDR1—osteoporosis	0.000274	0.0108	CbGpPWpGaD
Fospropofol—GABRA5—Orphan transporters—ANXA2—osteoporosis	0.000271	0.0107	CbGpPWpGaD
Fospropofol—GABRA3—Orphan transporters—ANXA2—osteoporosis	0.000266	0.0105	CbGpPWpGaD
Fospropofol—GABRA2—Orphan transporters—ANXA2—osteoporosis	0.000261	0.0103	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.000261	0.0103	CbGpPWpGaD
Fospropofol—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.00026	0.0103	CbGpPWpGaD
Fospropofol—GABRB3—Orphan transporters—ANXA2—osteoporosis	0.000259	0.0102	CbGpPWpGaD
Fospropofol—ALB—Lipoprotein metabolism—P4HB—osteoporosis	0.000256	0.0101	CbGpPWpGaD
Fospropofol—GABRG2—Orphan transporters—ANXA2—osteoporosis	0.000255	0.01	CbGpPWpGaD
Fospropofol—Vomiting—Estradiol—osteoporosis	0.000253	0.00293	CcSEcCtD
Fospropofol—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.00025	0.00986	CbGpPWpGaD
Fospropofol—Headache—Estradiol—osteoporosis	0.000249	0.00288	CcSEcCtD
Fospropofol—Nausea—Estradiol—osteoporosis	0.000236	0.00273	CcSEcCtD
Fospropofol—GABRA1—Orphan transporters—ANXA2—osteoporosis	0.000223	0.00877	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—CAP1—osteoporosis	0.000216	0.00853	CbGpPWpGaD
Fospropofol—GABRG3—GABA receptor activation—ADCY5—osteoporosis	0.000213	0.00839	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	0.00021	0.00828	CbGpPWpGaD
Fospropofol—GABRB1—GABA receptor activation—ADCY5—osteoporosis	0.00021	0.00826	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.000206	0.00812	CbGpPWpGaD
Fospropofol—GABRA6—GABA receptor activation—ADCY5—osteoporosis	0.000198	0.00782	CbGpPWpGaD
Fospropofol—GABRA4—GABA receptor activation—ADCY5—osteoporosis	0.000196	0.00772	CbGpPWpGaD
Fospropofol—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	0.000196	0.00771	CbGpPWpGaD
Fospropofol—GABRB2—GABA receptor activation—ADCY5—osteoporosis	0.000179	0.00706	CbGpPWpGaD
Fospropofol—GABRA5—GABA receptor activation—ADCY5—osteoporosis	0.000174	0.00686	CbGpPWpGaD
Fospropofol—GABRA3—GABA receptor activation—ADCY5—osteoporosis	0.000171	0.00673	CbGpPWpGaD
Fospropofol—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.00017	0.00671	CbGpPWpGaD
Fospropofol—GABRA2—GABA receptor activation—ADCY5—osteoporosis	0.000168	0.00662	CbGpPWpGaD
Fospropofol—GABRB3—GABA receptor activation—ADCY5—osteoporosis	0.000167	0.00657	CbGpPWpGaD
Fospropofol—GABRG2—GABA receptor activation—ADCY5—osteoporosis	0.000164	0.00646	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—PLEK—osteoporosis	0.000157	0.00619	CbGpPWpGaD
Fospropofol—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.00015	0.00593	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.00015	0.0059	CbGpPWpGaD
Fospropofol—GABRA1—GABA receptor activation—ADCY5—osteoporosis	0.000143	0.00564	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—RAP1A—osteoporosis	0.000142	0.0056	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—ALPL—osteoporosis	0.000136	0.00538	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—TLN1—osteoporosis	0.000135	0.00534	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—VCL—osteoporosis	0.000134	0.00527	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000129	0.00509	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000127	0.00502	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000121	0.00478	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—BMP2—osteoporosis	0.00012	0.00472	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000117	0.00463	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—FGA—osteoporosis	0.000101	0.00399	CbGpPWpGaD
Fospropofol—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	9.78e-05	0.00386	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	9.65e-05	0.0038	CbGpPWpGaD
Fospropofol—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	9.64e-05	0.0038	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	9.6e-05	0.00378	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—FGB—osteoporosis	9.22e-05	0.00363	CbGpPWpGaD
Fospropofol—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	9.12e-05	0.00359	CbGpPWpGaD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	9e-05	0.00355	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	8.83e-05	0.00348	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	8.78e-05	0.00346	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	8.24e-05	0.00325	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—ESR2—osteoporosis	8.14e-05	0.00321	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.08e-05	0.00318	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	8e-05	0.00315	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.96e-05	0.00314	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	7.86e-05	0.0031	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	7.78e-05	0.00306	CbGpPWpGaD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	7.72e-05	0.00304	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	7.67e-05	0.00302	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	7.62e-05	0.003	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	7.53e-05	0.00297	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.53e-05	0.00297	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.43e-05	0.00293	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—ADCY5—osteoporosis	7.36e-05	0.0029	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—SPP1—osteoporosis	7.26e-05	0.00286	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—ADCY5—osteoporosis	7.25e-05	0.00286	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—SOD2—osteoporosis	7.19e-05	0.00283	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	6.97e-05	0.00275	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—ADCY5—osteoporosis	6.86e-05	0.0027	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—GPX1—osteoporosis	6.85e-05	0.0027	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.8e-05	0.00268	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—ADCY5—osteoporosis	6.77e-05	0.00267	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.6e-05	0.0026	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	6.58e-05	0.00259	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—IRS2—osteoporosis	6.56e-05	0.00259	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.49e-05	0.00256	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.37e-05	0.00251	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.33e-05	0.0025	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—MTHFR—osteoporosis	6.33e-05	0.00249	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—WDR1—osteoporosis	6.26e-05	0.00247	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.22e-05	0.00245	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—ADCY5—osteoporosis	6.19e-05	0.00244	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—ADCY5—osteoporosis	6.01e-05	0.00237	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	6.01e-05	0.00237	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	5.93e-05	0.00234	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—ADCY5—osteoporosis	5.91e-05	0.00233	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—ADCY5—osteoporosis	5.8e-05	0.00229	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—ADCY5—osteoporosis	5.77e-05	0.00227	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—IRS1—osteoporosis	5.73e-05	0.00226	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	5.71e-05	0.00225	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—ADCY5—osteoporosis	5.66e-05	0.00223	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—ADCY5—osteoporosis	5.64e-05	0.00222	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—ADCY5—osteoporosis	5.55e-05	0.00219	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	5.45e-05	0.00215	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.43e-05	0.00214	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—ADCY5—osteoporosis	5.25e-05	0.00207	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—ADCY5—osteoporosis	5.19e-05	0.00204	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	5.03e-05	0.00198	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.98e-05	0.00196	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	4.95e-05	0.00195	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—ADCY5—osteoporosis	4.95e-05	0.00195	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CAP1—osteoporosis	4.95e-05	0.00195	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—ADCY5—osteoporosis	4.74e-05	0.00187	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	4.72e-05	0.00186	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	4.61e-05	0.00182	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—ADCY5—osteoporosis	4.61e-05	0.00182	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—ADCY5—osteoporosis	4.53e-05	0.00178	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	4.49e-05	0.00177	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—ADCY5—osteoporosis	4.45e-05	0.00175	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—ADCY5—osteoporosis	4.42e-05	0.00174	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—ADCY5—osteoporosis	4.34e-05	0.00171	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL6R—osteoporosis	4.33e-05	0.00171	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—IGF1—osteoporosis	4.17e-05	0.00164	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	4.09e-05	0.00161	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	3.97e-05	0.00157	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MGLL—osteoporosis	3.93e-05	0.00155	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—ADCY5—osteoporosis	3.79e-05	0.00149	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL1B—osteoporosis	3.75e-05	0.00148	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.67e-05	0.00145	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLEK—osteoporosis	3.59e-05	0.00142	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ANXA2—osteoporosis	3.59e-05	0.00142	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.58e-05	0.00141	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	3.35e-05	0.00132	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL1B—osteoporosis	3.3e-05	0.0013	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.11e-05	0.00123	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TLN1—osteoporosis	3.1e-05	0.00122	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VCL—osteoporosis	3.06e-05	0.0012	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.03e-05	0.00119	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.98e-05	0.00118	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	2.98e-05	0.00118	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.86e-05	0.00113	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.82e-05	0.00111	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.79e-05	0.0011	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TNF—osteoporosis	2.72e-05	0.00107	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	2.7e-05	0.00106	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—RAP1A—osteoporosis	2.55e-05	0.00101	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.55e-05	0.00101	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—TGFB1—osteoporosis	2.5e-05	0.000986	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.48e-05	0.000976	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.43e-05	0.000959	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.43e-05	0.000958	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—TNF—osteoporosis	2.39e-05	0.000942	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.39e-05	0.000942	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	2.38e-05	0.000939	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.38e-05	0.000936	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.33e-05	0.000919	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—FGA—osteoporosis	2.32e-05	0.000913	CbGpPWpGaD
Fospropofol—ALB—Metabolism—FDPS—osteoporosis	2.22e-05	0.000874	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PKM—osteoporosis	2.22e-05	0.000874	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL6—osteoporosis	2.2e-05	0.000866	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—TNF—osteoporosis	2.16e-05	0.000853	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—FGB—osteoporosis	2.11e-05	0.00083	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PGLS—osteoporosis	2.1e-05	0.000828	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPD2—osteoporosis	2.1e-05	0.000828	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.04e-05	0.000803	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL6—osteoporosis	1.93e-05	0.00076	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PNP—osteoporosis	1.92e-05	0.000758	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ATIC—osteoporosis	1.92e-05	0.000758	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	1.85e-05	0.000729	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL6—osteoporosis	1.75e-05	0.000688	CbGpPWpGaD
Fospropofol—ALB—Metabolism—OXCT1—osteoporosis	1.63e-05	0.000644	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CA2—osteoporosis	1.63e-05	0.000644	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MGLL—osteoporosis	1.59e-05	0.000628	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.5e-05	0.000592	CbGpPWpGaD
Fospropofol—ALB—Metabolism—IDH2—osteoporosis	1.35e-05	0.000534	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP27A1—osteoporosis	1.27e-05	0.000502	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ACP5—osteoporosis	1.24e-05	0.000488	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.22e-05	0.000482	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.17e-05	0.00046	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TPI1—osteoporosis	1.15e-05	0.000454	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.11e-05	0.000437	CbGpPWpGaD
Fospropofol—ALB—Metabolism—P4HB—osteoporosis	1.08e-05	0.000427	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GAPDH—osteoporosis	1.06e-05	0.000419	CbGpPWpGaD
Fospropofol—ALB—Metabolism—RAP1A—osteoporosis	1.04e-05	0.000408	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IGF1—osteoporosis	9.54e-06	0.000376	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.03e-06	0.000356	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ENO1—osteoporosis	8.37e-06	0.00033	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PSMA5—osteoporosis	8.25e-06	0.000325	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PSMA2—osteoporosis	8.25e-06	0.000325	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP19A1—osteoporosis	6.69e-06	0.000264	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TGFB1—osteoporosis	5.72e-06	0.000225	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ADCY5—osteoporosis	5.47e-06	0.000215	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPX1—osteoporosis	5.45e-06	0.000215	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MTHFR—osteoporosis	5.03e-06	0.000198	CbGpPWpGaD
Fospropofol—ALB—Metabolism—POMC—osteoporosis	4.02e-06	0.000158	CbGpPWpGaD
